HIV-1
Clinical trials for HIV-1 explained in plain language.
Never miss a new study
Get alerted when new HIV-1 trials appear
Sign up with your email to follow new studies for HIV-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental HIV vaccine aims to boost immunity in treated patients
Disease control TerminatedThis study tests a new vaccine designed to help the immune system fight HIV in people who are already on successful HIV medication. About 30 adults with well-controlled HIV will receive either the vaccine or a placebo. The goal is to see if the vaccine is safe and can create new …
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
HIV patients get continued access to key drug in safety study
Disease control OngoingThis study gives HIV-1 patients ongoing access to the drug etravirine until they can switch to a local treatment option. It includes 180 participants aged 2 and older who previously benefited from etravirine in a parent trial. The main goal is to monitor safety by tracking any si…
Matched conditions: HIV-1
Phase: PHASE3 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Can two antibodies flush out hidden HIV? new trial aims to reduce lifelong pills
Disease control OngoingThis early-stage study tests whether two experimental antibodies (3BNC117-LS and 10-1074-LS) are safe and can reduce the hidden HIV reservoirs that persist even when standard antiretroviral therapy (ART) keeps the virus undetectable. About 105 adults with HIV who are stable on AR…
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 05, 2026 11:54 UTC